PT1296694E - Probióticos na prevenção primária de doenças atópicas - Google Patents

Probióticos na prevenção primária de doenças atópicas Download PDF

Info

Publication number
PT1296694E
PT1296694E PT01951716T PT01951716T PT1296694E PT 1296694 E PT1296694 E PT 1296694E PT 01951716 T PT01951716 T PT 01951716T PT 01951716 T PT01951716 T PT 01951716T PT 1296694 E PT1296694 E PT 1296694E
Authority
PT
Portugal
Prior art keywords
atopic diseases
probiotics
primary prevention
atopic
diseases
Prior art date
Application number
PT01951716T
Other languages
English (en)
Inventor
Erika Isolauri
Seppo Salminen
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8558595&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1296694(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PT1296694E publication Critical patent/PT1296694E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei
PT01951716T 2000-06-20 2001-06-20 Probióticos na prevenção primária de doenças atópicas PT1296694E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20001460A FI110668B (fi) 2000-06-20 2000-06-20 Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn

Publications (1)

Publication Number Publication Date
PT1296694E true PT1296694E (pt) 2009-10-28

Family

ID=8558595

Family Applications (2)

Application Number Title Priority Date Filing Date
PT01951716T PT1296694E (pt) 2000-06-20 2001-06-20 Probióticos na prevenção primária de doenças atópicas
PT91642843T PT2201955T (pt) 2000-06-20 2001-06-20 Bifidobacterium lactis bb-12 na prevenção primária de doenças atópicas

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT91642843T PT2201955T (pt) 2000-06-20 2001-06-20 Bifidobacterium lactis bb-12 na prevenção primária de doenças atópicas

Country Status (9)

Country Link
US (2) US7112322B2 (pt)
EP (3) EP1296694B1 (pt)
AT (1) ATE439138T1 (pt)
AU (1) AU784921B2 (pt)
DE (2) DE60139554D1 (pt)
ES (3) ES2329549T3 (pt)
FI (1) FI110668B (pt)
PT (2) PT1296694E (pt)
WO (1) WO2001097822A1 (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
US20090257993A1 (en) 2003-12-17 2009-10-15 M Rabet Laura Lactic Acid Producing Bacteria and Lung Function
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1731137A1 (fr) * 2005-06-08 2006-12-13 Nestec S.A. Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles
MX2007004135A (es) * 2004-10-04 2007-06-15 Oreal Composicion cosmetica y/o dermatologica para pieles sensibles.
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
EP1642570A1 (fr) 2004-10-04 2006-04-05 L'oreal Composition cosmétique et/ou dermatologique pour peaux sensibles
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
EP2264164A1 (en) 2005-05-11 2010-12-22 Chr. Hansen A/S New antibiotic-sensitive lactic acid bacteria strains
JP2009067679A (ja) * 2005-12-27 2009-04-02 Univ Of Tokushima 抗ヒスタミン作用を有する医薬
CA2883256A1 (en) 2006-03-10 2007-09-20 N.V. Nutricia Use of non-digestible saccharides for strengthening the immune system
EP2084276A1 (en) 2006-11-15 2009-08-05 Chr. Hansen A/S New tetracycline-sensitive bifidobacteria strains
US20100092429A1 (en) 2006-12-11 2010-04-15 Danisco A/S Composition
KR20100014523A (ko) * 2007-02-22 2010-02-10 위르겐 슈레첸메이르 인간의 알레르기 반응을 예방, 억제 또는 제거하는 프로바이오틱 그램-양성 박테리아
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
US20090007924A1 (en) * 2007-04-30 2009-01-08 Iliff Edwin C Arbiter system and method of computerized medical diagnosis and advice
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
EP2668854B1 (en) 2008-03-28 2015-07-01 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
US20110053889A1 (en) * 2008-09-02 2011-03-03 Joanne Szabo Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
WO2011044516A2 (en) * 2009-10-09 2011-04-14 Prothera, Inc. Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
CN102269858A (zh) 2010-06-02 2011-12-07 北京智朗芯光科技有限公司 自动聚焦系统和自动聚焦方法
KR101850165B1 (ko) * 2010-06-30 2018-04-18 네스텍 소시에테아노님 피부 색소침착 조절용 식품 보충제에 있어서 카프타르산 및 락틱 박테리아의 용도
US9539269B2 (en) 2010-12-31 2017-01-10 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
SG191394A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2510932A1 (en) 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
EP2750523A1 (en) 2011-08-29 2014-07-09 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2617296A1 (en) * 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
EP2836224A4 (en) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
DK2861242T3 (en) 2012-06-18 2018-10-29 Heinz Co Brands H J Llc GLUTEN RELATED DISORDERS
WO2014052438A1 (en) 2012-09-25 2014-04-03 Regents Of The University Of Minnesota Methods for making and using antimicrobial peptides
EP2994150B1 (en) 2013-05-10 2019-03-06 H.J. Heinz Company Brands Llc Probiotics and methods of use
US20150064304A1 (en) * 2013-09-03 2015-03-05 Mario Medri Probiotic lozenge, method of making same, and uses thereof
WO2015071131A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
WO2015090349A1 (en) 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants
EP2886660A1 (en) * 2013-12-20 2015-06-24 Rigas Tehniska universitate A fluorescent in situ hybridization method for identification of a microorganism
JP6868562B2 (ja) 2014-10-31 2021-05-19 ペンデュラム セラピューティクス， インコーポレイテッド 障害の微生物的処置および診断に関する方法および組成物
WO2016149687A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
CA2950839C (en) * 2016-01-30 2023-09-12 Cooper Technologies Company Equipment rack and components thereof
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
EP3897678A1 (en) * 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
WO2021138599A1 (en) * 2020-01-03 2021-07-08 Forte Subsidiary, Inc. Cosmetic compositions
EP4251183A1 (en) * 2020-11-24 2023-10-04 Johnson & Johnson Consumer Inc. Methods of preventing, delaying or ameliorating atopic diseases
WO2024042229A1 (en) 2022-08-25 2024-02-29 Chr. Hansen A/S Bifidobacterium strains with improved stability

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5246591A (en) * 1990-07-13 1993-09-21 Pact, Incorporated Separation of metal ions on an anion exchange resin by chromatographic elution
BE1009359A7 (fr) * 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
GB9808579D0 (en) * 1998-04-22 1998-06-24 Novartis Nutrition Ag Improvements in or relating to organic compounds
JP4010062B2 (ja) * 1998-09-02 2007-11-21 医療法人社団青藍会 アトピー性皮膚炎を防ぐ保健食品
JP2000086524A (ja) 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases

Also Published As

Publication number Publication date
WO2001097822A1 (en) 2001-12-27
EP1296694B1 (en) 2009-08-12
ATE439138T1 (de) 2009-08-15
EP2201955A1 (en) 2010-06-30
US20030180272A1 (en) 2003-09-25
AU7257201A (en) 2002-01-02
US7988960B2 (en) 2011-08-02
US7112322B2 (en) 2006-09-26
PT2201955T (pt) 2019-11-25
FI20001460A (fi) 2001-12-21
EP2206507A1 (en) 2010-07-14
AU784921B2 (en) 2006-07-27
ES2754797T3 (es) 2020-04-20
US20060013806A1 (en) 2006-01-19
EP1296694A1 (en) 2003-04-02
FI110668B (fi) 2003-03-14
EP2201955B1 (en) 2019-08-14
ES2329549T3 (es) 2009-11-27
DE60139554D1 (de) 2009-09-24
EP2206507B1 (en) 2019-03-13
ES2721848T3 (es) 2019-08-05
DE01951716T1 (de) 2005-06-23
FI20001460A0 (fi) 2000-06-20

Similar Documents

Publication Publication Date Title
PT1296694E (pt) Probióticos na prevenção primária de doenças atópicas
ATE302265T1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
ATE534396T1 (de) Probiotische mikroorganismen zur verbesserung der muskulären funktion
HK1090289A1 (en) Antiallergic composition
IL156490A0 (en) Probiotic compounds derived from lactobacillus casei strain ke01
DE69930944D1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
DE60226254D1 (de) Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide
HUP0303728A2 (hu) Tápanyagkészítmény
EP1468075A4 (en) NEW LACTOBACILLE STRAIN AND USE THEREOF
HK1111883A1 (en) Use of a composition for preventing or treating respiratory infections and acute otitis media in infants
HK1094455A1 (en) Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
BR0207397A (pt) Cepa de bactéria de ácido láctico e composições comestìveis, drogas e produtos veterinários contendo-a
WO2007015132A3 (en) Use of specific lactic bacteria for the preparation of immunomodulating compositions
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
IL158738A0 (en) Novel use of 2-phenyl-substituted imidazotriazinones
WO2003045405A3 (fr) Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
CA2314775A1 (en) Novel lactic acid bacterial preparation that reduces triglycerides and cholesterol
EE05412B1 (et) Bifidobacterium'i perekonna probiootiliste tvede skriinimise meetod